PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.\', \'Departments of Medicine and Epidemiology, McGill University, Montreal, Quebec, Canada.\', \'Centre for Clinical Epidemiology, Lady Davis Institute - Jewish General Hospital, Montreal, Quebec, Canada.\', \'Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/pds.5217
?:hasPublicationType
?:journal
  • Pharmacoepidemiology and drug safety
is ?:pmid of
?:pmid
?:pmid
  • 33650210
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.329
?:rankingScore_hIndex
  • 80
?:title
  • Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all